Anne-marie Duliege - Net Worth and Insider Trading
Anne-marie Duliege Net Worth
The estimated net worth of Anne-marie Duliege is at least $0 dollars as of 2024-04-28. Anne-marie Duliege is the EVP & Chief Medical Officer of Rigel Pharmaceuticals Inc and owns about 0 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $0. Details can be seen in Anne-marie Duliege's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anne-marie Duliege has not made any transactions after 2018-09-17 and currently still holds the listed stock(s).
Transaction Summary of Anne-marie Duliege
Anne-marie Duliege Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anne-marie Duliege owns 3 companies in total, including Rigel Pharmaceuticals Inc (RIGL) , ChemoCentryx Inc (CCXI) , and Affymax Inc (AFFY) .
Click here to see the complete history of Anne-marie Duliege’s form 4 insider trades.
Insider Ownership Summary of Anne-marie Duliege
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc | 2018-09-17 | Chief Medical Officer |
| CCXI | ChemoCentryx Inc | 2014-03-25 | EVP & Chief of Strategic Dev. |
| AFFY | Affymax Inc | 2013-01-30 | Chief Medical Officer |
Anne-marie Duliege Latest Holdings Summary
Anne-marie Duliege currently owns a total of 1 stock. Anne-marie Duliege owns 0 shares of Rigel Pharmaceuticals Inc (RIGL) as of September 17, 2018, with a value of $0.
Latest Holdings of Anne-marie Duliege
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc | 2018-09-17 | 0 | 1.10 | 0 |
Holding Weightings of Anne-marie Duliege
Anne-marie Duliege Form 4 Trading Tracker
According to the SEC Form 4 filings, Anne-marie Duliege has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the sale of 153,000 shares on September 17, 2018, which brought Anne-marie Duliege around $535,500.
Insider Trading History of Anne-marie Duliege
- 1
Anne-marie Duliege Trading Performance
Anne-marie Duliege Ownership Network
Ownership Network List of Anne-marie Duliege
Ownership Network Relation of Anne-marie Duliege
Anne-marie Duliege Owned Company Details
What does Rigel Pharmaceuticals Inc do?
Who are the key executives at Rigel Pharmaceuticals Inc?
Anne-marie Duliege is the Chief Medical Officer of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Commercial Officer David A Santos , EVP & Chief Financial Officer Dean L Schorno , and Sr VP of Bus Dev and Com Ops Raul R Rodriguez .
Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary
Over the past 18 months, Anne-marie Duliege made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 73,234 shares made by Raul R Rodriguez , a net sale of 19,907 shares made by David A Santos , and a net sale of 18,017 shares made by Dean L Schorno .
In summary, during the past 3 months, insiders sold 80,041 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 80,041 shares. During the past 18 months, 116,547 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,547 shares.
Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rigel Pharmaceuticals Inc Insider Transactions
Anne-marie Duliege Mailing Address
Above is the net worth, insider trading, and ownership report for Anne-marie Duliege. You might contact Anne-marie Duliege via mailing address: 4001 Miranda Avenue, Palo Alto Ca 94304.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
